Pin Lean is a Lecturer in Bio-Law at Brunel Law School, joining Brunel University London in January 2021. Prior to joining Brunel University, she was an attorney on secondment with the Legal Services Team (based in Belgrave, London) in the General Counsel's Organization of American Express International, where she was a key senior legal counsel for the Asia-Pacific region.
Pin Lean is a member of the Brunel International Law Research Group, and an active member of the Centre for Artificial Intelligence: Social & Digital Innovations, and was recently selected to join the first Brunel Research Interdisciplinary Lab (BRIL) in September 2021. Externally, she is part of the ELSI2.0 Workspace, an international collaboratory on genomics and society research; a member of the European Association of Health Law (EAHL), and a General Manager of the Interest Group on Supranational Bio-Law of the EAHL. She has held visiting fellowships with the Centre for Health, Law and Emerging Technologies (HeLEX), NDPH (Medical Sciences Division), University of Oxford; the Centre for Ethics and Law in the Life Sciences (CELLs) at the University of Hannover, Germany; and participated in the Centre for Ethics and Law in Biomedicine (CELAB) in Central European University, Hungary.
Her research encompasses European, international, and comparative law for genome editing (with a focus on pre-implantation genetic diagnosis, reproductive technologies and women's bodies; and the proliferation of virulent gene-edited pathogens and global bio-security); propertization and commodification studies of genetic materials and biomedical technologies; and the ethico-legal governance for artificial intelligence (AI) systems (with a focus on protection of fundamental rights, spatial 'body citizenship' and bio-constitutional implications of the AI-augmented biological human body).
Pin Lean is currently working on a multi-trust funded priject for the World Health Organization (WHO), Food and Agriculture Organization (FAO) and the OiE (World Organization for Animal Health), on developing and piloting of a Tripartite One Health Assessment Tool for Antimicrobial Resistance Relevant Legislation. She is also simultaneously working on a project with researchers from the EAHL to produce a Joint Statement for the European Commission's 2021 Thematic Networks, with a proposal for Health as a Fundamental Value, as part of the EU Pharmaceutical Strategy.
PhD (nostrified in the UK), Doctorate in Juridical Science (Summa cum Laude) in Comparative Constitutional Law, Central European University
LLM (Merit) in Maritime Law and International Law, University of London
LLB (Hons) (2nd Upper Class Hons), University of London
Qualified Barrister & Solicitor of the Bar Council of Malaysia
Besides her role as a lecturer, Pin Lean is also the Director of Exchange and Study Abroad Programs for Brunel Law School. She also serves as the Law Society and Mooting Liaison with the student-led Law Society of Brunel Law School.
Newest selected publications
Mahalatchimy, A., Lau, PL., Li, P. and Flear, ML. (2021) 'Framing and legitimating EU legal regulation of human gene-editing technologies: key facets and functions of an imaginary'. Journal of Law and the Biosciences, 8 (2). pp. 1 - 30. ISSN: 2053-9711 Open Access Link
Lau, PL. (2019) 'Comparative Legal Frameworks for Pre-Implantation Embryonic Genetic Interventions'. Springer. ISSN 10: 3030223086 ISSN 13: 9783030223083
Lau, PL. (2019) 'The Extension of Legal Personhood in Artificial Intelligence.'. Revista de Bioética y Derecho, 46.Open Access Link
Lau, PL. (2017) 'The Genius & The Imbecile: Disentangling the 'Legal' Framework of Autonomy in Modern Liberal Eugenics, from Non-Therapeutic Gene Enhancement Use in Gene Editing Technologies'.Current Debates in Social Sciences Conference. Istanbul, Turkey. 14 - 16 December. Proceedings of Current Debates in Social Sciences Conference: Current Debates in International Relations and Law. pp. 301 - 324.Open Access Link